The conservation of CD44/CD24 ratio and ALDH1+ during tumor progression and metastasis, especially the expression of these markers in CTCs, provided possibilities to evaluate tumor stemness through the liquid biopsy, and therefore opened a new avenue towards the early diagnosis, the tumor progression monitoring, and the prognosis evaluation of cancers. This evidence concerns the gene ALDH1A1 and cancer.